TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/17108102

Cancer Res. 2006 Nov 15 66 22 10658-63

Download in:

View as

General Info

PMID
17108102